Current clinical trials examining LuPSMA

Video

“There's a hope that we can modulate PSMA expression with some drugs, increase the amount of PSMA on the tumors, [and] therefore increase the amount of radiation that we can target,” says Michael S. Hofman, MBBS (Hons), FRACP, FAANMS, FICIS.

In this video, Michael S. Hofman, MBBS (Hons), FRACP, FAANMS, FICIS, discusses the current clinical trials highlighted in the lecture, “LuPSMA: The Newest Treatment Class for Advanced Prostate Cancer,” presented recently at the 2021 Prostate Cancer Foundation Scientific Retreat. Hofman is a nuclear medicine physician and director of PROSTIC, Melbourne, Australia.

Related Videos
Phillip H. Kuo, MD, PhD, FACR, answers a question during a Zoom video interview
blurred image of a clinic hallway
Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
Man talking with doctor | Image Credit: © Chinnapong - stock.adobe.com
Dr. Brian F. Chapin in an interview with Urology Times
Dr. Brian F. Chapin in an interview with Urology Times
Brian F. Chapin, MD, answers a question during a Zoom video interview
Related Content
© 2023 MJH Life Sciences

All rights reserved.